C12N 2770/32134
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/32134 (Use of virus or viral component as vaccine) appears on 105 US grants and 134 published applications in this corpus.
Search patents in C12N- Granted patents
- 105
- Published applications
- 134
- Assignees
- 78
- Inventors
- 333
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 2 | 2 |
| 2005 | 0 | 5 |
| 2006 | 1 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 1 |
| 2009 | 4 | 3 |
| 2010 | 0 | 2 |
| 2011 | 1 | 5 |
| 2012 | 2 | 7 |
| 2013 | 1 | 4 |
| 2014 | 5 | 8 |
| 2015 | 4 | 7 |
| 2016 | 4 | 6 |
| 2017 | 7 | 7 |
| 2018 | 8 | 13 |
| 2019 | 12 | 14 |
| 2020 | 10 | 6 |
| 2021 | 12 | 9 |
| 2022 | 3 | 7 |
| 2023 | 3 | 7 |
| 2024 | 5 | 8 |
| 2025 | 4 | 5 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Foot-and-mouth disease virus-like particle antigen, vaccine composition, preparation method, and use thereof28 Apr 2026US 12,611,452 B2Pulike Biological Engineering, Inc.
- Development of mosaic vaccines against foot and mouth disease virus serotype O28 Oct 2025US 12,453,767 B2Kansas State University Research Foundation
- Foot-and-mouth disease vaccine29 Apr 2025US 12,285,478 B2The United States of America as represented by the Secretary of Agriculture
- Engineered Hansenula fungi efficiently expressing CA10 virus-like particles and uses thereof18 Mar 2025US 12,251,435 B2Beijing Minhai Biotechnology Co., Ltd.
- Foot-and-mouth disease virus-like particle antigen, and vaccine composition, preparation method, and application thereof18 Feb 2025US 12,226,472 B2Pulike Biological Engineering, Inc.
- Affordable universal fusion universal vaccine for foot and mouth disease infections9 Jul 2026US 2026/0191947 A1
- Pentameric toxin protein-based target protein fusion pentamer producing platform using viral nucleocapsid2 Jul 2026US 2026/0184745 A1University-Industry Foundation, Yonsei University
- Foot-and-mouth disease vaccine25 Jun 2026US 2026/0174842 A1The United States of America as represented by the Secretary of Agriculture
- Recombinant foot-and-mouth disease type a virus inducing strong adaptive immune response and overcoming interference from maternally-derived antibodies, and foot-and-mouth disease vaccine composition comprising same18 Jun 2026US 2026/0166137 A1Republic of Korea (Animal and Plant Quarantine Agency)
- Recombinant protein comprising protein derived from foot-and-mouth disease virus type o capsid protein and sfc protein and use thereof28 May 2026US 2026/0146065 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
Most cited
By later US patents
- Antigenically active amino acid sequences190US 4,708,871 ACommonwealth Serum Laboratories Commission · 1987
- Vaccines, the process for preparing the same and the applications thereof26US 3,983,229 AAgence Nationale de Valorisation de la Recherche (ANVAR) · 1976
- Small peptides with the specificity of foot and mouth disease viral antigens25US 4,605,512 ABiogen, Inc. · 1986
- Vaccine production process22US 4,049,494 AThe United States of America as represented by the Secretary of Agriculture · 1977
- Vaccines, the process for preparing the same and the applications thereof13US 4,075,321 AAgence Nationale de Valorisation de la Recherche (ANVAR) · 1978